Benutzer: Gast  Login
Titel:

[[11C]choline as a pharmacodynamic marker for docetaxel therapy. Response assessment in a LNCaP prostate cancer xenograft mouse model].

Dokumenttyp:
English Abstract; Journal Article
Autor(en):
Schwarzenböck, S; Sachs, D; Souvatzoglou, M; Schuster, T; Nawroth, R; Weirich, G; Treiber, U; Wester, HJ; Ziegler, S; Schwaiger, M; Senekowitsch-Schmidtke, R; Krause, BJ
Abstract:
The aim of this study was to determine whether [11C]choline can be used for docetaxel therapy response assessment in a LNCaP-prostate cancer xenograft mouse model using [11C]choline small-animal PET/CT. Animals, methods: The androgen-dependent human prostate cancer cell line LNCaP was implanted subcutaneously into the left flanks of 17 SCID-mice, 12.5 mg testosterone platelets were implanted in the neck wrinkle. All mice were injected 4-6 weeks after xenograft implantation with 37 MBq [11C]choli...     »
Zeitschriftentitel:
Nuklearmedizin
Jahr:
2013
Band / Volume:
52
Heft / Issue:
4
Seitenangaben Beitrag:
141-7
Sprache:
de
Volltext / DOI:
doi:10.3413/Nukmed-0521-12-07
PubMed:
http://view.ncbi.nlm.nih.gov/pubmed/23396481
Print-ISSN:
0029-5566
TUM Einrichtung:
Institut für Allgemeine Pathologie und Pathologische Anatomie; Institut für Medizinische Statistik und Epidemiologie; Klinik und Poliklinik für Nuklearmedizin; Urologische Klinik und Poliklinik
 BibTeX